Evidence map›Paper›PMID 21788351›Full record

ArticleThe Journal of physiology2011

(-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle.

Leonardo Nogueira, Israel Ramirez-Sanchez, Guy A Perkins, Anne Murphy, Pam R Taub, Guillermo Ceballos, Francisco J Villarreal, Michael C Hogan, Moh H Malek

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02490527 (Effects of Epicatechin on Patients With Statin-induced Mitochondrial Dysfunction and Impaired Exercise Capacity), which is not on this map. Cited by 109 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 3 pooled it
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02490527 nacompletednot on this mapstarted 2015, after this paper: background citation

Effects of Epicatechin on Patients With Statin-induced Mitochondrial Dysfunction and Impaired Exercise Capacity

TypeinterventionalSponsorUniversity of California, San DiegoRan2015 to 2021Enrolled19ConditionsStatin IntoleranceArmsPure epicatechin capsules (50mg), Simvastatin (40mg), Placebo
3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 3 syntheses or guidelines pooled it, 198 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Article
  16. Exercise pills for cardiometabolic health cannot mimic the exercise milieu.Trends in endocrinology and metabolism: TEM · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Leonardo NogueiraDepartment of Medicine, School of Medicine, University of California, San Diego, CA, USA.
Israel Ramirez-Sanchez
Guy A Perkins
Anne Murphy
Pam R Taub
Guillermo Ceballos
Francisco J Villarreal
Michael C Hogan
Moh H Malek
University of California, San Diego · USInstituto Politécnico Nacional · MXLa Jolla Alcohol Research · USWayne State University · US

Funding

VOLUMETRIC CONTOUR-BASED SURFACE RECONSTRUCTIONP41RR004050 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PASQUALE, ELENA B · 1989 to 2011
$28.0M
Oxygen dependence of ROS generation in contracting single isolated myofibersR01AR040155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HOGAN, MICHAEL C · 1996 to 2012
$3.4M
NCRR NIH HHS P41 RR004050NCRR NIH HHS RR004050NIAMS NIH HHS R01 AR040155
6 · The paper itself

Abstract

The flavanol (-)-epicatechin, a component of cacao (cocoa), has been shown to have multiple health benefits in humans. Using 1-year-old male mice, we examined the effects of 15 days of (-)-epicatechin treatment and regular exercise on: (1) exercise performance, (2) muscle fatigue, (3) capillarity, and (4) mitochondrial biogenesis in mouse hindlimb and heart muscles. Twenty-five male mice (C57BL/6N) were randomized into four groups: (1) water, (2) water-exercise (W-Ex), (3) (-)-epicatechin ((-)-Epi), and (4) (-)-epicatechin-exercise ((-)-Epi-Ex). Animals received 1 mg kg(-1) of (-)-epicatechin or water (vehicle) via oral gavage (twice daily). Exercise groups underwent 15 days of treadmill exercise. Significant increases in treadmill performance (∼50%) and enhanced in situ muscle fatigue resistance (∼30%) were observed with (-)-epicatechin. Components of oxidative phosphorylation complexes, mitofilin, porin, nNOS, p-nNOS, and Tfam as well as mitochondrial volume and cristae abundance were significantly higher with (-)-epicatechin treatment for hindlimb and cardiac muscles than exercise alone. In addition, there were significant increases in skeletal muscle capillarity. The combination of (-)-epicatechin and exercise resulted in further increases in oxidative phosphorylation-complex proteins, mitofilin, porin and capillarity than (-)-epicatechin alone. These findings indicate that (-)-epicatechin alone or in combination with exercise induces an integrated response that includes structural and metabolic changes in skeletal and cardiac muscles resulting in greater endurance capacity. These results, therefore, warrant the further evaluation of the underlying mechanism of action of (-)-epicatechin and its potential clinical application as an exercise mimetic.

Indexed as

AnimalsAntioxidantsCapillariesCatechinHindlimbIn Vitro TechniquesMaleMiceMice, Inbred C57BLMitochondria, MuscleModels, AnimalMuscle ContractionMuscle FatigueMuscle, SkeletalOxidation-ReductionPhysical Conditioning, AnimalAntioxidantsCatechin

Identifiers

PMID21788351
PMCPMC3208228
OpenAlexW2143904165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.